However, high stromal expression of S100A12 in hepatocellular cancer is associated with poor patient outcome [18], and a recent study shows that S100A12 expression in tissues of glioma patients is correlated to tumor grade and size [19]. This evidence concerns the gene S100A12 and central nervous system cancer.